AMED to Fund 9 More Company-Led COVID-19 Drug Projects Including StemRIM, Takeda

September 28, 2020
The Japan Agency for Medical Research and Development (AMED) has said that it will fund nine new projects led by companies to develop treatments for novel coronavirus, including those from StemRIM and Takeda Pharmaceutical. AMED invited a third round of...read more